Key indicators: single-crystal X-ray study; T = 298 K; mean (C-C) = 0.004 Å; R factor = 0.037; wR factor = 0.093; data-to-parameter ratio = 10.6.
The title compound, C 6 H 5 ClN 2 O 2 , crystallizes with two independent molecules in the asymmetric unit. Intermolecular C-HÁ Á ÁO hydrogen bonds stabilize the crystal structure.
Related literature
For aplication of pyridines, see: Madsen-Duggan et al. (2010) ; Meurer et al. (2005) ; Lié geois et al. (1993) ; Kagabu et al. (2005) . For related structures, see: Ng (2010) . For standard bond lengths, see: Allen et al. (1987) .
Experimental
Crystal data C 6 H 5 ClN 2 O 2 M r = 172.57 Orthorhombic, Pna2 1 a = 21.435 (6) Å b = 8.151 (2) Å c = 8.494 (2) Å V = 1484.0 (7) Å 3 Z = 8 Mo K radiation = 0.46 mm À1 T = 298 K 0.38 Â 0.24 Â 0.21 mm
Data collection
Bruker SMART CCD area-detector diffractometer 7071 measured reflections 2134 independent reflections 1749 reflections with I > 2(I) R int = 0.023 Refinement R[F 2 > 2(F 2 )] = 0.037 wR(F 2 ) = 0.093 S = 1.06 2134 reflections 201 parameters 1 restraint H-atom parameters constrained Á max = 0.20 e Å À3 Á min = À0.13 e Å À3 Absolute structure: Flack (1983), 139 Friedel pairs Flack parameter: À0.08 (8) Table 1 Hydrogen-bond geometry (Å , ).
Symmetry code: (i) Àx þ 1; Ày þ 1; z À 1 2 .
Data collection: SMART (Bruker, 1998) ; cell refinement: SAINT (Bruker, 1999) ; data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL.
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: HG5113). 
2-Chloro

Comment
Substituted pyridines are often used as pharmacophores in medicinal chemistry (Madsen-Duggan et al., 2010; Meurer et al., 2005) . 2-Chloro-5-methyl-3-nitropyridine (I) is important intermediate in the synthesis of some bioactive products (Liégeois, et al., 1993; Kagabu, et al., 2005) . The title compound was prepared by the chlorination of 2-hydroxy-5-methyl-3-nitropyridine with thionyl chloride. We present here the crystal structure of (I).
The title compound, C 6 H 5 ClN 2 O 2 , crystallizes with two independent molecules in the asymmetric unit. All bond lengths in the molecular are normal (Allen et al., 1987) and in a good agreement with those reported previously (Ng, 2010) . C-H···O intermolecular hydrogen bonds stabilize the crystal structure. (Table 1) .
Experimental
The title compound was synthesized by the reaction of 2-hydroxy-5-methyl-3-nitropyridine (0.01 mol) with thionyl chloride (15 ml) in the presence of a small amount of DMF at reflux (3 h). After evaporation, the reaction residue was diluted with water. The aqueous solution was extracted with dichloromethane, and the organic phase was dried and evaporated to afford the title product in 92% isolated yield. Crystals suitable for X-ray diffraction analysis were obtained by slow evaporation of a solution of the title compound in a hexane/methylene chloride mixture (1:1 v/v) at room temperature over a period of one week.
Refinement
All H atoms were found on difference maps, with C-H = 0.93-0.96 Å and included in the final cycles of refinement using a riding model, with U iso (H) = 1.2U eq (C) and 1.5U eq (C) for the methyl H atoms. 
